Results 31 to 40 of about 11,817 (223)
Effectiveness of repeated antivenom therapy for snakebite-related systemic complications
Journal of International Medical Research, 2019 Objective This study aimed to determine the effect of repeated antivenom therapy compared with that of single antivenom therapy for treating snakebite-related systemic complications.
Kyung Hoon Park +7 more
doaj +1 more source
Antivenom supply and demand: An analysis of antivenom availability and utilization in South Africa
African Journal of Emergency Medicine, 2023 Snakebites are a neglected tropical disease. In many areas, envenoming incidence and antivenom administration rates are unknown. This study compared antivenom (AV) availability to rates of envenoming and recommendations to treat (RTT) in South Africa.This retrospective study identified, extracted, and reviewed all cases of envenoming (snake bites and ...
Natalie R Neumann +6 more
openaire +3 more sources
Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb. [PDF]
, 2014 Medically important cases of snakebite in Europe are predominately caused by European vipers of the genus Vipera. The mainstay of snakebite therapy is polyclonal antibody therapy, referred to as antivenom.
Al-Abdulla, Ibrahim +4 more
core +2 more sources
Toxins, 2020 Coastal taipan (Oxyuranus scutellatus) envenoming causes life-threatening neuromuscular paralysis in humans. We studied the time period during which antivenom remains effective in preventing and arresting in vitro neuromuscular block caused by taipan ...
Umesha Madhushani +4 more
doaj +1 more source
Antivenoms for Snakebite Envenomings
Inflammation & Allergy - Drug Targets, 2011 Animal-derived antivenoms constitute the mainstay in the therapy of snakebite envenoming. Antivenoms are manufactured by immunizing animals, usually horses, with venoms from a single or several medically-relevant snake species. Antivenoms are constituted by either whole IgG molecules or the immunoglobulin fragments F(ab')₂ and Fab, obtained by ...
Gutiérrez, José María +3 more
openaire +4 more sources
Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease? [PDF]
, 2017 Snakebite envenoming is a major public health burden in tropical parts of the developing world. In sub-Saharan Africa, neglect has led to a scarcity of antivenoms threatening the lives and limbs of snakebite victims.
Andersen, Mikael R +3 more
core +2 more sources
Journal of Venomous Animals and Toxins including Tropical Diseases, 2007 Scorpion envenomation remains a real health problem in many countries. In scorpionism cases, it is often recommended that patients be treated with species-specific antivenom. Androctonus crassicauda venom has been used as antigen for antivenom production
O. Ozkan +5 more
doaj +1 more source
Funnel-web spider bite: a systematic review of recorded clinical cases [PDF]
, 2005 The document attached has been archived with permission from the editor of the Medical Journal of Australia (09 January 2008). An external link to the publisher’s copy is included.Objective: To investigate species-specific envenoming rates and spectrum ...
Balit, C. +9 more
core +2 more sources
Acute Medicine & Surgery, 2016 Aim Redback spiders are rapidly becoming a nationwide problem in Japan. The domestic production of antivenom for redback spider bites has been started because of extremely low supply.
Toru Hifumi +11 more
doaj +1 more source
Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites. [PDF]
PLoS Neglected Tropical Diseases, 2015 There is limited information on antivenom pharmacokinetics. This study aimed to investigate the pharmacokinetics of an Indian snake antivenom in humans with Russell's viper bites.Patient data and serial blood samples were collected from patients with ...
Geoffrey K Isbister +13 more
doaj +1 more source